Related references
Note: Only part of the references are listed.Concepts for agonistic targeting of CD40 in immuno-oncology
David M. Richards et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
Mechanistic basis of co-stimulatory CD40-CD40L ligation mediated regulation of immune responses in cancer and autoimmune disorders
Tikam Chand Dakal et al.
IMMUNOBIOLOGY (2020)
Enhanced efficacy and limited systemic cytokine exposure with membrane-anchored interleukin-12 T-cell therapy in murine tumor models
Ling Zhang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity
Junyun Lai et al.
NATURE IMMUNOLOGY (2020)
Bystander IFN-γ activity promotes widespread and sustained cytokine signaling altering the tumor microenvironment
Ronan Thibaut et al.
NATURE CANCER (2020)
The metabolic enzyme arginase-2 is a potential target for novel immune modulatory vaccines
Stine Emilie Weis-Banke et al.
ONCOIMMUNOLOGY (2020)
The T-win® technology: immune-modulating vaccines
Mads Hald Andersen
SEMINARS IN IMMUNOPATHOLOGY (2019)
STING signaling remodels the tumor microenvironment by antagonizing myeloid-derived suppressor cell expansion
Chuan-xia Zhang et al.
CELL DEATH AND DIFFERENTIATION (2019)
Principles of adoptive T cell therapy in cancer
Ozcan Met et al.
SEMINARS IN IMMUNOPATHOLOGY (2019)
STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models
Weiqing Jing et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Blockade of CTLA-4 and PD-1 Enhances Adoptive T-cell Therapy Efficacy in an ICOS-Mediated Manner
Lewis Zhichang Shi et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Dual CTLA-4 and PD-L1 Blockade Inhibits Tumor Growth and Liver Metastasis in a Highly Aggressive Orthotopic Mouse Model of Colon Cancer
E. Fiegle et al.
NEOPLASIA (2019)
Endogenous T cells prevent tumor immune escape following adoptive T cell therapy
Scott R. Walsh et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Enhanced CAR-T cell activity against solid tumors by vaccine boosting through the chimeric receptor
Leyuan Ma et al.
SCIENCE (2019)
Are Conventional Type 1 Dendritic Cells Critical for Protective Antitumor Immunity and How?
Jean-Charles Cancel et al.
FRONTIERS IN IMMUNOLOGY (2019)
Dendritic cell subsets in T cell programming: location dictates function
S. C. Eisenbarth
NATURE REVIEWS IMMUNOLOGY (2019)
Inflammation induced PD-L1-specific T cells
Shamaila Munir et al.
CELL STRESS (2019)
Combined sublethal irradiation and agonist anti-CD40 enhance donor T cell accumulation and control of autochthonous murine pancreatic tumors
Lindsay K. Ward-Kavanagh et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Unmasking Pancreatic Cancer: Epitope Spreading After Single Antigen Chimeric Antigen Receptor T-Cell Therapy in a Human Phase I Trial
Max Heckler et al.
GASTROENTEROLOGY (2018)
Immune suppression and reversal of the suppressive tumor microenvironment
Kanako Shimizu et al.
INTERNATIONAL IMMUNOLOGY (2018)
An Antigen-Free, Plasmacytoid Dendritic Cell-Targeting Immunotherapy To Bolster Memory CD8+ T Cells in Nonhuman Primates
Yuji Masuta et al.
JOURNAL OF IMMUNOLOGY (2018)
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
S. L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Spontaneous T-cell responses against Arginase-1 in the chronic myeloproliferative neoplasms relative to disease stage and type of driver mutation
Mia Aaboe Jorgensen et al.
ONCOIMMUNOLOGY (2018)
Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, efficacy, and Limitations
Judith A. Seidel et al.
FRONTIERS IN ONCOLOGY (2018)
STING agonist therapy in combination with PD-1 immune checkpoint blockade enhances response to carboplatin chemotherapy in high-grade serous ovarian cancer
Abdi Ghaffari et al.
BRITISH JOURNAL OF CANCER (2018)
The Role of Toll-Like Receptor in Inflammation and Tumor Immunity
Xiaohong Cen et al.
FRONTIERS IN PHARMACOLOGY (2018)
Long-term outcomes of a phase I study of agonist CD40 antibody and CTLA-4 blockade in patients with metastatic melanoma
David L. Bajor et al.
ONCOIMMUNOLOGY (2018)
Ex vivo AKT-inhibition facilitates generation of polyfunctional stem cell memory-like CD8+ T cells for adoptive immunotherapy
Charlotte M. Mousset et al.
ONCOIMMUNOLOGY (2018)
The 2018 Nobel Prize in medicine goes to cancer immunotherapy (editorial for BMC cancer)
Zong Sheng Guo
BMC CANCER (2018)
Enhancing T Cell Receptor Stability in Rejuvenated iPSC-Derived T Cells Improves Their Use in Cancer Immunotherapy
Atsutaka Minagawa et al.
CELL STEM CELL (2018)
Novel Strategies for Peptide-Based Vaccines in Hematological Malignancies
Uffe Klausen et al.
FRONTIERS IN IMMUNOLOGY (2018)
Trial Watch: Toll-like receptor agonists in cancer immunotherapy
Melody Smith et al.
ONCOIMMUNOLOGY (2018)
The Role of Type 1 Conventional Dendritic Cells in Cancer Immunity
Jan P. Boettcher et al.
TRENDS IN CANCER (2018)
NY-ESO-1 Vaccination in Combination with Decitabine Induces Antigen-Specific T-lymphocyte Responses in Patients with Myelodysplastic Syndrome
Elizabeth A. Griffiths et al.
CLINICAL CANCER RESEARCH (2018)
Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma
Elizabeth A. Reap et al.
CANCER RESEARCH (2018)
Dendritic cells as gatekeepers of tolerance
Ari Waisman et al.
SEMINARS IN IMMUNOPATHOLOGY (2017)
Toxicity profile of approved anti-PD-1 monoclonal antibodies in solid tumors: a systematic review and meta-analysis of randomized clinical trials
Ricardo Costa et al.
ONCOTARGET (2017)
Radiation-induced decrease of CD8+dendritic cells contributes to Thl/Th2 shift
Hu Liu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors
Tyrel T. Smith et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Vaccination to improve the persistence of CD19CAR gene-modified T cells in relapsed pediatric acute lymphoblastic leukemia
C. Rossig et al.
LEUKEMIA (2017)
Notch-mediated conversion of activated T cells into stem cell memory-like T cells for adoptive immunotherapy
Taisuke Kondo et al.
NATURE COMMUNICATIONS (2017)
CD40L Expression Allows CD8+ T Cells to Promote Their Own Expansion and Differentiation through Dendritic Cells
Neil Q. Tay et al.
FRONTIERS IN IMMUNOLOGY (2017)
Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy
Stefani Spranger et al.
CANCER CELL (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
Immunogenic cell death in cancer and infectious disease
Lorenzo Galluzzi et al.
NATURE REVIEWS IMMUNOLOGY (2017)
CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date
Jae H. Park et al.
BLOOD (2016)
Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy
Rebecca Gardner et al.
BLOOD (2016)
Generation of clinical-grade CD19-specific CAR-modified CD8+ memory stem cells for the treatment of human B-cell malignancies
Marianna Sabatino et al.
BLOOD (2016)
Critical Role for CD103+/CD141+ Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma
Edward W. Roberts et al.
CANCER CELL (2016)
Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
Joseph L. Benci et al.
CELL (2016)
Safety, immune and clinical responses in metastatic melanoma patients vaccinated with a long peptide derived from indoleamine 2,3-dioxygenase in combination with ipilimumab
Jon Bjoern et al.
CYTOTHERAPY (2016)
Imiquimod activates p53-dependent apoptosis in a human basal cell carcinoma cell line
Shi-Wei Huang et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2016)
Neoantigen landscape dynamics during human melanoma-T cell interactions
Els M. E. Verdegaal et al.
NATURE (2016)
Established T Cell-Inflamed Tumors Rejected after Adaptive Resistance Was Reversed by Combination STING Activation and PD-1 Pathway Blockade
Ellen Moore et al.
CANCER IMMUNOLOGY RESEARCH (2016)
PD-L1 peptide co-stimulation increases immunogenicity of a dendritic cell-based cancer vaccine
Shamaila Munir Ahmad et al.
ONCOIMMUNOLOGY (2016)
Toll-like receptor agonist therapy can profoundly augment the antitumor activity of adoptively transferred CD8+ T cells without host preconditioning
Michelle H. Nelson et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
TIGIT and PD-1 impair tumor antigen-specific CD8+ T cells in melanoma patients
Joe-Marc Chauvin et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
TIGIT predominantly regulates the immune response via regulatory T cells
Sema Kurtulus et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Nivolumab in Previously Untreated Melanoma without BRAF Mutation
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity
Olivier Demaria et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Enhancement of adoptive T cell transfer with single low dose pretreatment of doxorubicin or paclitaxel in mice
Fei-Ting Hsu et al.
ONCOTARGET (2015)
Radiotherapy combined with TLR7/8 activation induces strong immune responses against gastrointestinal tumors
Sebastian Schoelch et al.
ONCOTARGET (2015)
Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
Leticia Corrales et al.
CELL REPORTS (2015)
The multifaceted biology of plasmacytoid dendritic cells
Melissa Swiecki et al.
NATURE REVIEWS IMMUNOLOGY (2015)
TLR Signals Induce Phagosomal MHC-I Delivery from the Endosomal Recycling Compartment to Allow Cross-Presentation
Priyanka Nair-Gupta et al.
CELL (2014)
Treg Cells Expressing the Coinhibitory Molecule TIGIT Selectively Inhibit Proinflammatory Th1 and Th17 Cell Responses
Nicole Joller et al.
IMMUNITY (2014)
STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
Seng-Ryong Woo et al.
IMMUNITY (2014)
A novel systemically administered Toll-like receptor 7 agonist potentiates the effect of ionizing radiation in murine solid tumor models
Amy L. Adlard et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
IL-12 and type I interferon prolong the division of activated CD8 T cells by maintaining high-affinity IL-2 signaling in vivo
Gabriel R. Starbeck-Miller et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Immune complexes stimulate CCR7-dependent dendritic cell migration to lymph nodes
Menna R. Clatworthy et al.
NATURE MEDICINE (2014)
Postoperative dendritic cell vaccine plus activated T-cell transfer improves the survival of patients with invasive hepatocellular carcinoma
Koichi Shimizu et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
TGFβ Inhibition Prior to Hypofractionated Radiation Enhances Efficacy in Preclinical Models
Kristina H. Young et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Radioimmunotherapy for oncological indications
Norma Bloy et al.
ONCOIMMUNOLOGY (2014)
Chimeric antigen receptor engineered T cells can eliminate brain tumors and initiate long-term protection against recurrence
Laura A. Johnson et al.
ONCOIMMUNOLOGY (2014)
Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T cells despite lower Ag uptake than myeloid dendritic cell subsets
Jurjen Tel et al.
BLOOD (2013)
Systemic delivery of a TLR7 agonist in combination with radiation primes durable antitumor immune responses in mouse models of lymphoma
Simon J. Dovedi et al.
BLOOD (2013)
Regeneration of Human Tumor Antigen-Specific T Cells from iPSCs Derived from Mature CD8+ T Cells
Raul Vizcardo et al.
CELL STEM CELL (2013)
Characterization of direct radiation-induced immune function and molecular signaling changes in an antigen presenting cell line
Jennifer J. Parker et al.
CLINICAL IMMUNOLOGY (2013)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
Targeting Uptake Receptors on Human Plasmacytoid Dendritic Cells Triggers Antigen Cross-Presentation and Robust Type I IFN Secretion
Jurjen Tel et al.
JOURNAL OF IMMUNOLOGY (2013)
Co-Stimulation through 4-1BB/CD137 Improves the Expansion and Function of CD8+ Melanoma Tumor-Infiltrating Lymphocytes for Adoptive T-Cell Therapy
Jessica Ann Chacon et al.
PLOS ONE (2013)
Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
Lijun Sun et al.
SCIENCE (2013)
IL-10 control of dendritic cells in the skin
Bjorn E. Clausen et al.
ONCOIMMUNOLOGY (2013)
Gene-engineered T cells for cancer therapy
Michael H. Kershaw et al.
NATURE REVIEWS CANCER (2013)
Levels of peripheral CD4+FoxP3+ regulatory T cells are negatively associated with clinical response to adoptive immunotherapy of human cancer
Xin Yao et al.
BLOOD (2012)
Antigen loss and tumor-mediated immunosuppression facilitate tumor recurrence
Brian M. Olson et al.
EXPERT REVIEW OF VACCINES (2012)
Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells
Barbara Drobits et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Agonistic Antibody to CD40 Boosts the Antitumor Activity of Adoptively Transferred T Cells In Vivo
Chengwen Liu et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Tumor cells, rather than dendritic cells, deliver antigen to the lymph node for cross-presentation
Alison M. McDonnell et al.
ONCOIMMUNOLOGY (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Indoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulators
Rikke Baek Sorensen et al.
BLOOD (2011)
Cyclophosphamide Synergizes with Type I Interferons through Systemic Dendritic Cell Reactivation and Induction of Immunogenic Tumor Apoptosis
Giovanna Schiavoni et al.
CANCER RESEARCH (2011)
The Efficacy of Radiotherapy Relies upon Induction of Type I Interferon-Dependent Innate and Adaptive Immunity
Byron C. Burnette et al.
CANCER RESEARCH (2011)
Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
Steven A. Rosenberg et al.
CLINICAL CANCER RESEARCH (2011)
TGFβ1 Inhibition Increases the Radiosensitivity of Breast Cancer Cells In Vitro and Promotes Tumor Control by Radiation In Vivo
Fanny Bouquet et al.
CLINICAL CANCER RESEARCH (2011)
Use of defined TLR ligands as adjuvants within human vaccines
Malcolm S. Duthie et al.
IMMUNOLOGICAL REVIEWS (2011)
Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells
Mercedes B. Fuertes et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Type I interferon is selectively required by dendritic cells for immune rejection of tumors
Mark S. Diamond et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Type I IFNs Control Antigen Retention and Survival of CD8α+ Dendritic Cells after Uptake of Tumor Apoptotic Cells Leading to Cross-Priming
Silvia Lorenzi et al.
JOURNAL OF IMMUNOLOGY (2011)
Cutting Edge: TIGIT Has T Cell-Intrinsic Inhibitory Functions
Nicole Joller et al.
JOURNAL OF IMMUNOLOGY (2011)
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma
Ilyar Sheyhidin et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis
Salome Gonzalez-Reyes et al.
BMC CANCER (2010)
Dendritic cell recovery post-lymphodepletion: a potential mechanism for anti-cancer adoptive T cell therapy and vaccination
Mohamed Labib Salem et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy
Gerty Schreibelt et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Cyclophosphamide induces bone marrow to yield higher numbers of precursor dendritic cells in vitro capable of functional antigen presentation to T cells in vivo
Mohamed L. Salem et al.
CELLULAR IMMUNOLOGY (2010)
Clinical Responses in a Phase II Study Using Adoptive Transfer of Short-term Cultured Tumor Infiltration Lymphocytes in Metastatic Melanoma Patients
Michal J. Besser et al.
CLINICAL CANCER RESEARCH (2010)
LAG-3 Expression Defines a Subset of CD4+CD25highFoxp3+ Regulatory T Cells That Are Expanded at Tumor Sites
Chiara Camisaschi et al.
JOURNAL OF IMMUNOLOGY (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer
Junko Matsuzaki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Feedback control of regulatory T cell homeostasis by dendritic cells in vivo
Guillaume Darrasse-Jeze et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Recovery from Cyclophosphamide-Induced Lymphopenia Results in Expansion of Immature Dendritic Cells Which Can Mediate Enhanced Prime-Boost Vaccination Antitumor Responses In Vivo When Stimulated with the TLR3 Agonist Poly(I:C)
Mohamed L. Salem et al.
JOURNAL OF IMMUNOLOGY (2009)
The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells
Xin Yu et al.
NATURE IMMUNOLOGY (2009)
Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity
Christian S. Hinrichs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Radiation-induced bystander signalling in cancer therapy
Kevin M. Prise et al.
NATURE REVIEWS CANCER (2009)
Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation
Juliette Mouries et al.
BLOOD (2008)
Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history
Patricia Fitzgerald-Bocarsly et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2008)
Antigen-presentation properties of plasmacytoid dendritic cells
Jose A. Villadangos et al.
IMMUNITY (2008)
Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens
Mark E. Dudley et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
Hiroki Ishikawa et al.
NATURE (2008)
Molecular characteristics of immunogenic cancer cell death
A. Tesniere et al.
CELL DEATH AND DIFFERENTIATION (2008)
LAG-3 regulates CD8+T cell accumulation and effector function in murine self- and tumor-tolerance systems
Joseph F. Grosso et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Single administration of low dose cyclophosphamide augments the antitumor effect of dendritic cell vaccine
Ji-Yan Liu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo
Jose A. Villadangos et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells
Georg Stary et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Steady-state and inflammatory dendritic-cell development
Ken Shortman et al.
NATURE REVIEWS IMMUNOLOGY (2007)
The tumor-draining lymph node as an immune-privileged site
David H. Munn et al.
IMMUNOLOGICAL REVIEWS (2006)
Adoptive immunotherapy for cancer: building on success
L Gattinoni et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
N Casares et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy
JH Zhou et al.
JOURNAL OF IMMUNOLOGY (2005)
Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells
L Gattinoni et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
IL-21 influences the frequency, phenotype, and affinity of the antigen-specific CD8 T cell response
YQ Li et al.
JOURNAL OF IMMUNOLOGY (2005)
Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells
CA Klebanoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
A critical function for type I interferons in cancer immunoediting
GP Dunn et al.
NATURE IMMUNOLOGY (2005)
Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells
L Gattinoni et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Enhanced type I interferon signaling and recruitment of chemokine receptor CXCR3-expressing lymphocytes into the skin following treatment with the TLR7-agonist imiquimod
J Wenzel et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2005)
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma
ME Dudley et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4
HC Probst et al.
NATURE IMMUNOLOGY (2005)
Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy
CA Klebanoff et al.
TRENDS IN IMMUNOLOGY (2005)
Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function
R Zeng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Persistence of multiple tumor-specific T-Cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy
JH Zhou et al.
JOURNAL OF IMMUNOTHERAPY (2005)
Activation of dendritic cells: translating innate into adaptive immunity
CRE Sousa
CURRENT OPINION IN IMMUNOLOGY (2004)
Dendritic cells strongly boost the antitumor activity of adoptively transferred T cells in vivo
YY Lou et al.
CANCER RESEARCH (2004)
Cutting edge: Persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy
PF Robbins et al.
JOURNAL OF IMMUNOLOGY (2004)
Irradiation up-regulates CD80 expression through two different mechanisms in spleen B cells, B lymphoma cells, and dendritic cells
H Torihata et al.
IMMUNOLOGY (2004)
Broadening of epitope recognition during immune rejection of ErbB-2-positive tumor prevents growth of ErbB-2-negative tumor
SA Pilon et al.
JOURNAL OF IMMUNOLOGY (2003)
Natural selection of tumor variants in the generation of tumor escape phenotypes
HT Khong et al.
NATURE IMMUNOLOGY (2002)
CD40 ligation conditions dendritic cell antigen-presenting function through sustained activation of NF-κB
BJ O'Sullivan et al.
JOURNAL OF IMMUNOLOGY (2002)
Induction of interleukin 10-producing, nonproliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells
H Jonuleit et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Role of tumor cell apoptosis in tumor antigen migration to the draining lymph nodes
B Bonnotte et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
